Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 61–61 | Cite as

Belimumab

Infections, bladder cancer and possible demyelinating syndrome: 4 case reports
Case report
  • 21 Downloads

Reference

  1. Fanouriakis A, et al. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. Seminars in Arthritis and Rheumatism 48: 467-474, No. 3, Dec 2018. Available from: URL: http://doi.org/10.1016/j.semarthrit.2018.02.014 -GreeceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations